A Two-Hit Model for Development of Multiple Endocrine Neoplasia Type 2B by RET Mutations
- 24 February 2000
- journal article
- case report
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 268 (3), 804-808
- https://doi.org/10.1006/bbrc.2000.2227
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2JAMA, 1996
- Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of theRET proto-oncogeneInternational Journal of Cancer, 1996
- Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2AHuman Genetics, 1996
- RET proto-oncogene mutations in French MEN 2A and FMTC familiesHuman Molecular Genetics, 1994
- Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1994
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHuman Molecular Genetics, 1994
- Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTCNature Genetics, 1994
- A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaNature, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993